Warning: The NCBI web site requires JavaScript to function. more...
Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides.
Steinstraesser L, Tippler B, Mertens J, Lamme E, Homann HH, Lehnhardt M, Wildner O, Steinau HU, Uberla K.
Retrovirology. 2005 Jan 18;2:2.
Related citations
In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique.
Esimone CO, Grunwald T, Wildner O, Nchinda G, Tippler B, Proksch P, Uberla K.
J Appl Microbiol. 2005;99(6):1346-55.
Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach.
Esimone CO, Grunwald T, Nworu CS, Kuate S, Proksch P, Uberla K.
Chemotherapy. 2009;55(2):119-26. Epub 2009 Jan 21.
Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression.
Wachinger M, Kleinschmidt A, Winder D, von Pechmann N, Ludvigsen A, Neumann M, Holle R, Salmons B, Erfle V, Brack-Werner R.
J Gen Virol. 1998 Apr;79 ( Pt 4):731-40.
Antisense-mediated inhibition of human immunodeficiency virus (HIV) replication by use of an HIV type 1-based vector results in severely attenuated mutants incapable of developing resistance.
Lu X, Yu Q, Binder GK, Chen Z, Slepushkina T, Rossi J, Dropulic B.
J Virol. 2004 Jul;78(13):7079-88.
Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.
Albiol Matanic VC, Castilla V.
Int J Antimicrob Agents. 2004 Apr;23(4):382-9.
Inhibiting lentiviral replication by HEXIM1, a cellular negative regulator of the CDK9/cyclin T complex.
Shimizu S, Urano E, Futahashi Y, Miyauchi K, Isogai M, Matsuda Z, Nohtomi K, Onogi T, Takebe Y, Yamamoto N, Komano J.
AIDS. 2007 Mar 12;21(5):575-82.
Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env.
Braun SE, Lu XV, Wong FE, Connole M, Qiu G, Chen Z, Slepushkina T, Slepushkin V, Humeau LM, Dropulic B, Johnson RP.
Hum Gene Ther. 2007 Jul;18(7):653-64.
Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds.
Bona R, Andreotti M, Buffa V, Leone P, Galluzzo CM, Amici R, Palmisano L, Mancini MG, Michelini Z, Di Santo R, Costi R, Roux A, Pommier Y, Marchand C, Vella S, Cara A.
Antimicrob Agents Chemother. 2006 Oct;50(10):3407-17.
Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
Vandekerckhove L, Christ F, Van Maele B, De Rijck J, Gijsbers R, Van den Haute C, Witvrouw M, Debyser Z.
J Virol. 2006 Feb;80(4):1886-96.
Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ, Liu X, He J.
Gene Ther. 2005 Jul;12(14):1133-44. Erratum in: Gene Ther. 2005 Aug;12(16):1289.
Inhibition of HIV type 1 replication using lentiviral-mediated delivery of mutant tRNA(Lys3)A58U.
Renda MJ, Bradel-Tretheway B, Planelles V, Bambara RA, Dewhurst S.
AIDS Res Hum Retroviruses. 2004 Dec;20(12):1324-34.
Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
Bahner I, Sumiyoshi T, Kagoda M, Swartout R, Peterson D, Pepper K, Dorey F, Reiser J, Kohn DB.
Mol Ther. 2007 Jan;15(1):76-85.
Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O, Berkhout B.
J Gene Med. 2007 Sep;9(9):743-50.
Inhibitory effect of tachyplesin I on the proliferation of human immunodeficiency virus in vitro.
Morimoto M, Mori H, Otake T, Ueba N, Kunita N, Niwa M, Murakami T, Iwanaga S.
Chemotherapy. 1991;37(3):206-11.
Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y, Sun S, Oparaocha I, Humeau L, Davis B, Cohen R, Binder G, Chang YN, Slepushkin V, Dropulic B.
J Gene Med. 2005 Jun;7(6):818-34. Erratum in: J Gene Med. 2005 Jun;7(6):835.
Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny.
Dimitrova DI, Yang X, Reichenbach NL, Karakasidis S, Sutton RE, Henderson EE, Rogers TJ, Suhadolnik RJ.
J Interferon Cytokine Res. 2005 Jun;25(6):345-60.
Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs.
Chiba-Mizutani T, Miura H, Matsuda M, Matsuda Z, Yokomaku Y, Miyauchi K, Nishizawa M, Yamamoto N, Sugiura W.
J Clin Microbiol. 2007 Feb;45(2):477-87. Epub 2006 Dec 20.
Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequences in determining its toxicity.
Ahmad A, Azmi S, Srivastava RM, Srivastava S, Pandey BK, Saxena R, Bajpai VK, Ghosh JK.
Biochemistry. 2009 Nov 24;48(46):10905-17.
In vitro antiviral activity of dermaseptins against herpes simplex virus type 1.
Belaid A, Aouni M, Khelifa R, Trabelsi A, Jemmali M, Hani K.
J Med Virol. 2002 Feb;66(2):229-34.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on